Our Take
Automation that removes user input sounds like pure progress until you realize it shifts risk from the user to the algorithm—and the algorithm doesn't always know what the user knows.
Why it matters
Diabetes management today still requires patients to announce meals so insulin dosing can adjust. Fully closed-loop devices aim to eliminate that friction. But removing the human from the loop means trading user control for algorithmic confidence, a tradeoff that matters most for the people living with the condition daily.
Do this week
Product teams: audit your closed-loop prototype against at least three real-world meal scenarios where your algorithm would diverge from patient intent (skipped meals, unusual timing, mixed macros) before claiming full automation.
Three companies are building toward fully closed-loop insulin systems
Insulet, MiniMed, and Tandem Diabetes Care are all developing next-generation systems designed to eliminate meal announcements from diabetes management. Today, insulin pump users must manually log or announce meals so the device can calculate and deliver appropriate insulin doses. The new wave of devices aims to remove that manual step entirely, letting the pump adjust insulin delivery based solely on continuous glucose monitoring data and algorithmic prediction.
This is not a minor convenience. Diabetes management is cognitively and operationally exhausting. Every meal requires a decision, a number entry, and trust that the system will respond correctly. Removing that burden is the stated goal of the closed-loop race.
Automation trades user knowledge for algorithmic certainty
The appeal is obvious: fewer decisions, less mental load, less room for human error. But fully closed-loop systems introduce a different kind of risk: the algorithm must now make assumptions the user used to verify.
A user knows when they are about to eat a high-fat meal that will absorb slowly. They know when stress or illness will change how their body responds to insulin. They know when they changed their routine. The algorithm sees only glucose numbers and time. Removing the meal announcement removes a safety gate where the user could inject context the device cannot infer.
The tradeoff is not hypothetical. Patients living with diabetes will notice immediately if the closed-loop system over- or under-delivers insulin in scenarios the algorithm did not anticipate. The manufacturers are racing toward automation, but practitioners and patients need to understand what information is being sacrificed in the process.
Validate closed-loop claims against real usage, not just lab data
When closed-loop devices launch, the benchmarks will be clean: lab conditions, logged meals, predictable routines. Real life is messier. Before recommending or deploying a fully closed-loop system, test it against the meal patterns and life schedules your actual patient population lives with. Ask the manufacturer for failure mode data: what happens when the algorithm is wrong? Can the user override it? How quickly? How often do users revert to semi-automated mode?
The companies racing toward full automation are solving a real problem. But automation that works in controlled settings sometimes fails quietly in the chaos of daily life. Your job is to surface those failures before they reach patients.